Duke University
Joseph Ladowski is a graduate of the University of Chicago and obtained his MD-PhD from the University of Alabama-Birmingham Heersink School of Medicine’s Medical Scientist Training Program (MSTP). His PhD was obtained under the guidance of Dr. A Joseph Tector, a leading surgeon-scientist in the field of xenotransplantation, and his thesis work focused on the role of the swine major histocompatibility complex (MHC) as a potential target of preformed antibodies. Some of his work in Dr. Tector’s lab during this time led to the recognition of the swine MHC as a potential xenoantigen. Following his graduation he entered the general surgery residency program at Duke University and spent a two-year research sabbatical in the labs of Dr. Allan Kirk and Stuart Knechtle, researching the potential therapeutic targets of transplant tolerance and mechanisms of antibody development following transplantation. He is currently finishing his general surgery residency and continuing his research into understanding the xenoantigen barrier at a population-level.
Disclosure information not submitted.
Scientific Awards Presentation
Wednesday, October 23, 2024
10:00 AM – 10:15 AM US PDT
Michael Schmiederer Research Support
Wednesday, October 23, 2024
10:08 AM – 10:15 AM US PDT
Closing Session: Is your Lab Ready for Xenotransplantation?
Friday, October 25, 2024
10:30 AM – 12:00 PM US PDT
The Clinical Implementation of Xenotransplantation – What Patients Can Benefit?
Friday, October 25, 2024
10:30 AM – 10:52 AM US PDT